Clinical Trial Update: The Efficacy of Adjunctive Use of Ondansetron in Patients With Sepsis and Septic Shock [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating adjunctive ondansetron for patients with sepsis and septic shock across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: Noha Mansour | Conditions: Sepsis, Septic Shock | Phase 1, Phase 2 | Status: UNKNOWN